SkyTides
Long/short equity, deep value, special situations, value

History Could Repeat Itself At Hologic

The current state of Hologic (NASDAQ:HOLX) is summed up well by Amit Hazan of SunTrust Banks in an article on Firstwordmedtech.com. Mr. Hazan stated "I just don't see a pathway forward that could happen without the equity really getting hurt." This article will explain how Hologic has destroyed shareholder value in the past at an extreme level. We will also explain how this may be occurring again right now. At this point, if an investor is still long Hologic, they need to consider whether there are better investments available to them then Hologic and whether the risk, which is obviously high, outweighs any significant potential return on investment, which is not likely to be seen until at least...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details